R&D The future of precision psychiatry The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and
News J&J scores EU approval for Tecvayli combo in second line Johnson & Johnson's multiple myeloma regimen is now approved as a second line treatment in both the US and the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
